title: Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension.
abstract: Lung vascular lesions in pulmonary arterial hypertension (PAH) are characterized by enlarged, vacuolated ("megalocytotic") pulmonary arterial endothelial (PAEC) and smooth muscle cells (PASMC). We have recently proposed that dysfunction of vesicle tethers, soluble N-ethylmaleimide-sensitive factor attachment proteins (SNAPs), and SNAP receptors (SNAREs), leading to disruptions of intracellular trafficking in the Golgi to plasma membrane (centrifugal) and the plasma membrane to cell interior (centripetal) directions is a key causal mechanism in this disease. In PAH, there was a reciprocal relationship between loss of caveolin-1 (cav-1) in PAECs and increased expression of "activated" tyrosine-phosphorylated STAT3 (PY-STAT3) associated with a block in centrifugal trafficking to/through the Golgi organelle. In the present study, we investigated 1) whether centripetal trafficking of STAT3 and PY-STAT3 in PAECs and PASMCs was membrane-associated, and 2) whether this might be affected in PAH. Immunofluorescence and live cell imaging studies showed that, in both PAEC and PASMC, STAT3 was associated with cytoplasmic vesicles partially colocalizing with markers of the endolysosomal compartments (clathrin, EEA1, Rab5, Rab11, and LAMP1). Overexpression of cav-1 increased the targeting of STAT3 to lysosomes and inhibited STAT3 transcriptional activity. Exposure of PAECs to monocrotaline (MCT) pyrrole, which causes PAH in the rat, led to a loss of caveolar STAT3 with increased sequestration of STAT3 and PY-STAT3 in endosomes. In vivo, marked cytoplasmic sequestration of activated PY-STAT3 was a common feature in PAEC in the rat/MCT model and in cells in the proliferative arterial and plexiform lesions in PAH in humans. These data highlight the epigenetic regulation of centripetal cytokine and growth-factor signaling pathways and its modulation in PAH.
authors: Rm. 201 Basic Sciences Bldg., Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY 10595, USA.
authors: Somshuvra
authors: S
authors: Mukhopadhyay
authors: Mehul
authors: M
authors: Shah
authors: Fang
authors: F
authors: Xu
authors: Kirit
authors: K
authors: Patel
authors: Rubin M
authors: RM
authors: Tuder
authors: Pravin B
authors: PB
authors: Sehgal
mesh_terms: D000818:Animals; D002417:Cattle; D051242:Caveolin 1 / Q000096:biosynthesis; D002451:Cell Compartmentation; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology* / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000503:physiopathology*; D008247:Lysosomes / Q000502:physiology*; D008297:Male; D016686:Monocrotaline / Q000031:analogs & derivatives; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000502:physiology*; D019704:Protein Disulfide-Isomerases / Q000096:biosynthesis; D021381:Protein Transport / Q000187:drug effects; D051381:Rats; D050796:STAT3 Transcription Factor / Q000502:physiology*
chemical_list: C495537:Cav1 protein, rat; D051242:Caveolin 1; D050796:STAT3 Transcription Factor; C494088:Stat3 protein, rat; C014114:monocrotaline pyrrole; D016686:Monocrotaline; D019704:Protein Disulfide-Isomerases; C085868:PDIA3 protein, human